ATRC
AtriCure, Inc. NASDAQ Listed Aug 5, 2005$58.32
After hrs
$58.58
+0.45%
Mkt Cap $3.0B
52w Low $25.36
95.5% of range
52w High $59.88
50d MA $44.44
200d MA $35.43
P/E (TTM)
280.1x
EV/EBITDA
98.7x
P/B
5.7x
Debt/Equity
0.2x
ROE
-2.3%
P/FCF
57.7x
RSI (14)
80.50
ATR (14)
$2.08
Beta
1.43
50d MA
$44.44
200d MA
$35.43
Avg Volume
1.1M
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
7555 Innovation Way · Mason, OH 45040 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | AMC | -0.00 | 0.18 | +9999.0% | 33.00 | +2.1% | +6.2% | +6.6% | +6.4% | +2.9% | -1.8% | — |
| May 5, 2026 | AMC | -0.07 | 0.00 | +103.1% | 29.39 | -4.2% | -4.7% | -0.7% | -5.5% | +0.1% | +1.5% | — |
| Feb 17, 2026 | AMC | -0.04 | 0.06 | +249.8% | 32.97 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% | — |
| Oct 29, 2025 | AMC | -0.11 | -0.01 | +90.9% | 35.44 | +4.0% | -3.8% | +1.3% | -1.5% | -3.8% | -1.3% | — |
| Jul 29, 2025 | AMC | -0.15 | -0.02 | +86.7% | 31.73 | +18.8% | +10.7% | -0.1% | -2.0% | +5.6% | +3.3% | — |
| Apr 29, 2025 | AMC | -0.25 | -0.14 | +44.0% | 34.65 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% | — |
| Feb 12, 2025 | AMC | -0.23 | -0.08 | +65.2% | 42.36 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% | — |
| Oct 29, 2024 | AMC | -0.20 | -0.17 | +15.0% | 29.43 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% | — |
| Jul 30, 2024 | AMC | -0.15 | -0.17 | -13.3% | 22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% | — |
| May 1, 2024 | AMC | -0.21 | -0.25 | -19.0% | 24.76 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% | — |
| Feb 15, 2024 | AMC | -0.22 | -0.21 | +4.5% | 34.21 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% | — |
| Nov 1, 2023 | AMC | -0.30 | -0.20 | +33.3% | 35.01 | +8.3% | +4.5% | +1.1% | +2.4% | -1.0% | -1.2% | — |
| Jul 25, 2023 | AMC | -0.27 | -0.12 | +55.6% | 53.19 | +6.7% | +8.5% | -5.2% | +1.1% | +0.0% | +1.6% | — |
| May 2, 2023 | AMC | -0.34 | -0.23 | +32.4% | 43.94 | +7.2% | +10.0% | -2.5% | +2.6% | -1.2% | +0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 | UBS | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | BTIG | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Oppenheimer | Downgrade | Outperform → Perform | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Citizens | Maintains | Market Outperform → Market Outperform | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 12 | Needham | Maintains | Buy → Buy | — | $32.90 | $33.01 | +0.3% | -3.3% | +2.7% | +1.0% | -2.2% | +0.4% |
| Dec 16 | JP Morgan | Maintains | Overweight → Overweight | — | $41.04 | $41.35 | +0.8% | +0.1% | -0.7% | -1.0% | +1.4% | +1.7% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $35.44 | $36.86 | +4.0% | -3.8% | +1.3% | -1.5% | -3.8% | -1.3% |
| Jul 30 | Needham | Maintains | Buy → Buy | — | $31.73 | $37.70 | +18.8% | +10.7% | -0.1% | -2.0% | +5.6% | +3.3% |
| Apr 30 | Needham | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | BTIG | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | UBS | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 2 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $33.36 | $32.52 | -2.5% | +2.3% | -3.5% | -4.9% | +0.9% | -3.1% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.37 | $33.83 | -1.6% | -7.4% | +1.4% | +3.4% | +2.3% | -3.5% |
| Mar 27 | Needham | Maintains | Buy → Buy | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 27 | BTIG | Maintains | Buy → Buy | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 27 | JP Morgan | Maintains | Overweight → Overweight | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 21 | Needham | Maintains | Buy → Buy | — | $34.82 | $34.53 | -0.8% | -3.7% | +4.6% | -0.7% | -3.5% | +2.2% |
| Feb 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Needham | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | BTIG | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Stifel | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 11 | JP Morgan | Maintains | Overweight → Overweight | — | $42.02 | $41.93 | -0.2% | -1.2% | +2.0% | -6.5% | +3.4% | -6.6% |
| Feb 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $41.00 | $41.48 | +1.2% | +2.5% | -1.2% | +2.0% | -6.5% | +3.4% |
| Jan 22 | Needham | Maintains | Buy → Buy | — | $39.63 | $39.82 | +0.5% | -0.3% | +2.2% | +0.5% | +0.6% | +3.1% |
| Jan 13 | Needham | Maintains | Buy → Buy | — | $31.41 | $33.07 | +5.3% | +9.5% | +0.9% | +6.6% | +1.8% | +2.2% |
| Dec 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.25 | $34.56 | +0.9% | -0.9% | +0.1% | -2.0% | -1.6% | -3.4% |
| Oct 30 | UBS | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Needham | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Oppenheimer | Maintains | Outperform → Outperform | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | JP Morgan | Maintains | Overweight → Overweight | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | BTIG | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | Needham | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | JP Morgan | Maintains | Overweight → Overweight | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 8 | Needham | Maintains | Buy → Buy | — | $23.67 | $23.82 | +0.6% | -7.7% | +1.8% | -0.2% | +5.4% | -0.9% |
| May 2 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| May 2 | Needham | Maintains | Buy → Buy | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| May 2 | JP Morgan | Maintains | Overweight → Overweight | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| Apr 23 | Oppenheimer | Upgrade | Perform → Outperform | — | $22.71 | $23.92 | +5.3% | +2.0% | -0.5% | -1.9% | +2.5% | +0.9% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $27.61 | $26.59 | -3.7% | -6.2% | -2.3% | -4.8% | -4.9% | +0.9% |
| Feb 16 | Needham | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Feb 16 | UBS | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Feb 16 | Stifel | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | GROVES REGINA EDir | — | Sell | 5,313 | $54.22 | $288K | 34,546 | +0.77% | +0.38% |
| Sep 8, 2026 | Privitera SalvatoreOff | Chief Technical Officer | Sell | 3,657 | $55.00 | $201K | 147,264 | +2.98% | +3.47% |
| Sep 2, 2026 | Privitera SalvatoreOff | Chief Technical Officer | Sell | 7,763 | $52.50 | $408K | 150,921 | +4.29% | +2.29% |
| Aug 24, 2026 | Dahlquist Karl S.Off | Chief Legal Officer | Sell | 9,370 | $48.89 | $458K | 87,319 | +2.28% | +7.50% |
| Aug 5, 2026 | Prange KarenDir | — | Sell | 3,564 | $38.80 | $138K | 22,809 | +0.60% | +1.86% |
| Aug 5, 2026 | Yuen MaggieDir | — | Sell | 3,500 | $38.42 | $134K | 14,015 | +0.60% | +1.86% |
| Jul 29, 2026 | Noznesky Justin JOff | Chief Mktg & Strategy Officer | Sell | 6,182 | $38.80 | $240K | 100,219 | -5.95% | +0.38% |
| Jul 28, 2026 | WEHRWEIN SVENDir | — | Sell | 25,000 | $37.84 | $946K | 40,518 | -5.95% | +0.38% |
| Jul 28, 2026 | Doraiswamy VinayakOff | Chief Scientific Officer | Sell | 6,000 | $38.88 | $233K | 86,511 | -5.95% | +0.38% |
| May 15, 2026 | Doraiswamy VinayakOff | Chief Scientific Officer | Sell | 5,000 | $28.13 | $141K | 91,875 | +1.12% | +1.84% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 4,474,548 | $125M | New | Jun 2026 |
| 2 | Hood River Capital Management Llc | 3,117,545 | $89M | Added | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 3,127,195 | $87M | Added | Jun 2026 |
| 4 | Vanguard Capital Management Llc | 2,190,413 | $61M | Added | Jun 2026 |
| 5 | Marshall Wace, Llp | 1,467,524 | $42M | Added | Mar 2026 |
| 6 | Divisadero Street Capital Management, Lp | 1,159,955 | $33M | New | Mar 2026 |
| 7 | Neuberger Berman Group Llc | 1,050,282 | $30M | Reduced | Mar 2026 |
| 8 | Voya Investment Management Llc | 712,329 | $28M | Added | Dec 2025 |
| 9 | Champlain Investment Partners, Llc | 971,111 | $28M | Reduced | Mar 2026 |
| 10 | Morgan Stanley | 692,232 | $27M | Added | Dec 2025 |
| 11 | Bnp Paribas Asset Management Holding S.a. | 897,419 | $25M | Reduced | Jun 2026 |
| 12 | Bank Of America Corp /de/ | 768,561 | $22M | Added | Mar 2026 |
| 13 | Point72 Asset Management, L.p. | 604,380 | $17M | New | Jun 2026 |
| 14 | Massachusetts Financial Services Co /ma/ | 580,621 | $16M | New | Jun 2026 |
| 15 | Aqr Capital Management Llc | 544,123 | $15M | Added | Jun 2026 |
| 16 | Two Sigma Investments, Lp | 525,795 | $15M | Reduced | Jun 2026 |
| 17 | Qube Research & Technologies Ltd | 454,791 | $13M | Added | Mar 2026 |
| 18 | Northern Trust Corp | 449,599 | $13M | Added | Mar 2026 |
| 19 | Norges Bank | 374,362 | $10M | New | Jun 2026 |
| 20 | Nuveen, Llc | 365,825 | $10M | Added | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.97B
Enterprise Value
$2.68B
P/E (TTM)
280.07x
Forward P/E
777.60x
PEG Ratio
2.21x
P/B
5.66x
P/S
4.89x
P/FCF
57.67x
EV/EBITDA
98.72x
Shares Out
47.8M
Financials (TTM)
Revenue
$569.6M
Net Income
$10.6M
EBITDA
$27.2M
Free Cash Flow
$48.3M
Op Cash Flow
$57.3M
EPS Basic
$-0.24
EPS Diluted
$0.21
EPS Forward
$0.07
Gross Margin
76.2%
Op Margin
2.4%
Net Margin
1.8%
Balance Sheet
Total Assets
$654.2M
Total Liab.
$162.2M
Total Equity
$491.9M
Cash
$167.4M
LT Debt
$73.4M
Book Value/Sh
$10.30
Debt/Equity
0.18x
Current Ratio
3.96
Quick Ratio
2.99
Returns & Growth
ROE
-2.3%
ROA
-1.8%
ROIC
-0.6%
Rev Growth YoY
+14.9%
EPS Growth YoY
+74.7%
Price Returns
2W
+10.8%
1M
+22.0%
3M
+104.3%
6M
+100.1%
12M
+59.5%
Technicals
52W High
$59.88
52W Low
$25.36
50d MA
$44.44
200d MA
$35.43
RSI (14)
80.50
ATR (14)
$2.08
Beta
1.43
Avg Volume
1.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.67
High
$55.00
Low
$44.00
Median
$53.00
Data updated apr 24, 2026 7:42pm
· Source: financialmodelingprep.com